Navigation Links
NicOx Announces Departure of Damian Marron for CEO Position
Date:5/27/2008

SOPHIA ANTIPOLIS, France, May 27 /PRNewswire-FirstCall/ -- NicOx S.A. (Euronext Paris: COX) today announced that Damian Marron, Executive Vice President of Corporate Development, will be leaving the company on May 30th to become Chief Executive Officer of an early clinical stage biopharmaceutical company. Damian's responsibilities will be assumed by Sanjiv Sharma, Vice President Commercial Affairs and Gavin Spencer, Senior Director Business Development.

Michele Garufi, Chairman and CEO of NicOx, commented: "Since joining NicOx in 2002, Damian has made a great contribution to the growth and success of the Company, during which time we have advanced our lead compound naproxcinod into an extensive phase 3 clinical trial program and signed significant collaborative agreements with both Pfizer and Merck, amongst others. Damian has helped to establish a strong corporate development team, which will focus on the next phase of NicOx' development as a fully integrated biopharmaceutical company. We wish Damian every success in this exciting new opportunity with his new company."

Damian Marron said: "It has been a privilege to work at NicOx. During my six years, I have gained invaluable experience and have had the opportunity to broaden my skills such that I have now been offered this great opportunity to lead a biotechnology company. NicOx has established itself as one of Europe's leading biotechnology companies with a highly promising lead product and excellent relationships in the pharmaceutical industry. With a first rate management team in place to execute NicOx' strategy of becoming an integrated pharmaceutical company, I believe this is an excellent time to move on to the new challenge of the role of CEO."

NicOx (Bloomberg: COX:FP, Reuters: NCOX.PA) a product-driven biopharmaceutical company dedicated to the development and future commercialization of investigational drugs for unmet medical needs. NicOx is applying its proprietary nitric oxid
'/>"/>

SOURCE NicOx S.A.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. NicOx Signs Agreement for the Commercial Manufacture of Naproxcinod Drug Substance
2. NicOx Initiates Two Large ABPM Studies for Naproxcinod in Hypertensive Patients with Osteoarthritis
3. NicOx to Present at Financial Conferences in New York on November 27, 28 and 29
4. NicOx Opens U.S. Headquarters in New Jersey
5. CellCyte Genetics Corporation Announces Launch of Comprehensive Web site Powered by PRNewswire Investor Room Backend Technology
6. Favrille Announces Results from Phase 3 Registration Trial of Specifid in Patients with Follicular B-Cell Non-Hodgkins Lymphoma
7. Dragon Pharma Announces June 26, 2008 for 2008 Annual Shareholders Meeting
8. Cardium Therapeutics Announces Annual Meeting of Stockholders to be Held June 5, 2008
9. Oncolytics Biotech Inc. Announces Issuance of 9th Canadian Patent
10. Amnis Announces Release of Its Extended Depth of Field Option for The ImageStream(R) System
11. Amarin Announces Completion of the First Tranche of $60 Million Private Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... December 23, 2014 GMO corn cases ... company, Syngenta, are in the process of being consolidated ... consolidated case is In Re: Syngenta AG MIR 162 ... Court for the District of Kansas. , Management of ... handed over to U.S. District Judge John W. Lungstrum.* ...
(Date:12/24/2014)... MD (PRWEB) December 23, 2014 ... into law H.R. 83, the Omnibus and Continuing ... first time, made hydrocephalus a condition eligible to ... Programs (CDMRP) administered by the Department of Defense ... with its allies on Capitol Hill, is celebrating ...
(Date:12/24/2014)... 2014 Nashville Fertility Center announced that ... for the American Society for Reproductive Medicine (ASRM), a ... in reproductive medicine. In his new role as ... executive board and will have a voice in furthering ... actively supported ASRM since 1984 when he joined while ...
(Date:12/24/2014)... 2014 China Biologic Products, Inc. (NASDAQ: ... fully integrated plasma-based biopharmaceutical company in ... subsidiary, Shandong Taibang Biological Products Co. Ltd., has ... China Food and Drug Administration (the "CFDA") for ... disclosed in the Company,s public filings, the CFDA ...
Breaking Biology Technology:Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2Rare Brain Condition Now Eligible for Department of Defense Research Dollars 2Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 2Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 3China Biologic Receives GMP Certification for New Coagulation Factor Facility 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 3
... one way businesses can create organic growth (or growth other ... (NPD) is Rubbermaid , which launches a new product ... existing markets or new markets. The most difficult kind of ... market. The easiest is a new product into an existing ...
... electron micrograph of E. coli. Source: NAIAD Biodefense ... up research on disease-causing pathogens, including ones that could ... of Wisconsin-Madison will team with an information technology company, ... publicly accessible library of data on these infectious agents ...
... on a plastic slide. Source: National Institute of ... small business innovation research (SBIR) grants totaling more than ... year by the National Institutes of Health and the ... is a cash infusion to do further product development ...
Cached Biology Technology:Seven reasons new technology product development goes astray 2Seven reasons new technology product development goes astray 3Seven reasons new technology product development goes astray 4UW-Madison joins effort to build public pathogen bioinformatics database 2GenTel claims $900,000 in federal grants this year for biochip research 2
(Date:12/17/2014)... YORK , Dec. 15, 2014  HITLAB ... Good Clinical Practices (GCP) audit to confirm its ... (FDA) regulations. This accomplishment enables HITLAB to conduct ... utilizing the highest principles for patient safety and ... improve global healthcare access, quality, and delivery with ...
(Date:12/17/2014)...  Automation is fundamentally transforming the travel experience ... international borders. Over the past decade, ePassports, biometric ... travelers to self process through border control via ... an increasing number of airports, seaports, and land ... to Maxine Most , Principal at Acuity ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has ... in India 2015-2019" report to their offering. ... this market is the adoption of multimodal biometric ... characteristic of an individual for verification and identification ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... ... ... , ... , , , , ...
... Two species of damselfish may look identicalnot to mention ... the fish, all of us are essentially colorblind. A new ... , a Cell Press publication, reveals that the fish can ... shape of the ultraviolet (UV) patterns on their faces. ...
... scientists for a half-century. Models clearly show that ... responding differently to the availability of resources. Then why ... Competitors like black gums and red maples have ... U.S. forests, yet species-level data offer scant proof that ...
Cached Biology News:ModiFace Launches iLab: An iPhone and iPad App Experimentation Laboratory 2ModiFace Launches iLab: An iPhone and iPad App Experimentation Laboratory 3Fish can recognize a face based on UV pattern alone 2Forest tree species diversity depends on individual variation 2Forest tree species diversity depends on individual variation 3
TRIzol Reagents are ready-to-use monophasic solutions of phenol and guanidine isothiocyanate suitable for isolating total RNA DNA and proteins (16)....
... total protein western blot (WtPAN) ... tissue specific protein expression in ... protein is included in each ... for comparison between different western ...
...
IHC detection kit for BrdU in cells and tissues...
Biology Products: